作者: Walter D Blessing , Alan J Stolier , Stephen C Teng , John S Bolton , George M Fuhrman
DOI: 10.1016/S0002-9610(02)00948-0
关键词:
摘要: Background: When lymphazurin became unavailable to our institution, we elected employ methylene blue perform sentinel node mapping for patients with breast cancer. The purpose of this study was compare and performing Methods: We evaluated experience from April 1, 2001 March 31, 2002. Patients were divided into two groups based on the dye used lymphatic mapping. compared evaluate results procedure. Results: During period a total 199 mapping, 87 112 blue. similar in demonstrating success procedure, nodes identified per case, technique identification (colloid or dye, both). Conclusions: In initial experience, appears be equivalent